CONSORT-Children and Adolescents (CONSORT-C) 2026 extension statement: enhancing the reporting and impact of

Ami Baba1, Maureen Smith2, Beth K Potter3

  • 1Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada.

Insights

New CONSORT-Children and Adolescents (CONSORT-C) 2026 guidelines improve reporting for paediatric randomized controlled trials (RCTs). This ensures better use of research findings for children and adolescents, reducing waste.

Area of Science:

  • * Clinical Trials Methodology
  • * Pediatric Research
  • * Health Research Reporting Standards

Background:

  • * High-quality randomized controlled trials (RCTs) in children and adolescents are crucial for informing healthcare decisions.
  • * Current reporting practices often lack completeness and transparency, hindering critical evaluation of pediatric RCTs.
  • * Standardized, evidence-based reporting guidelines are needed to reduce research waste in pediatric RCTs.

Purpose of the Study:

  • * To introduce the CONSORT-Children and Adolescents (CONSORT-C) 2026 reporting guideline.
  • * To enhance the quality and completeness of reporting for pediatric RCTs involving participants aged 0-19 years.
  • * To provide a minimum set of reporting items reflecting the priorities of all stakeholders.

Main Methods:

  • * Development informed by the EQUATOR Network framework.
  • * Literature review to identify candidate reporting items.
  • * Input from a Youth Advisory Group and a Family Caregiver Advisory Group.
  • * International Delphi study, consensus meeting, and pilot testing.

Main Results:

  • * CONSORT-C 2026 includes a checklist with 13 new reporting items.
  • * One item is youth-generated, and six are youth-endorsed.
  • * An accompanying explanation and elaboration paper provides detailed guidance and examples.

Conclusions:

  • * CONSORT-C 2026 offers a minimum standard for reporting pediatric RCTs.
  • * Implementation aims to optimize the usability and reproducibility of trial results.
  • * Adoption of CONSORT-C 2026 is expected to reduce research waste and improve evidence-based practice for young people.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Sex Linked Disorders01:43

Sex Linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.